Visiongain Publishes Urology Laser Market Report 2021-2031

16 February 2021
Pharma

Visiongain has published a new report on Urology Laser Market Report 2021-2031: Forecasts by Type of Laser (Holmium Laser, Thulium Laser, Neodymium, Green Laser Light, Diode Laser, Erbium), Applications (Benign Prostatic Hyperplasia (BPH), Kidney Stones, Tumour, Strictures). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Urology Laser market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031. Rise in the number of patients suffering from urology-related illnesses, rising preference for minimally-intrusive surgeries, and technological developments are some of the factors driving the market growth.

COVID-19 Impact on Urology Laser Market
The COViD-19 pandemic impact on the Urology Laser Market growth is considered to be modest as the market is directly influenced by the spread of the kidney related disorders globally. The spread of pandemic is not making any negative impact on the growth of Urology Laser market.

Market Drivers
The need for laser in urology process is increasing due to effective laser tissue interfaceprovided by these systems. Moreover, improvements in lasers and fiberoptics have created anamalgamation of endoscopes (small-diameter endoscopic instruments) and laser technology that can reach in the parts of human body which are otherwise difficult to reach using hand or scalpel. Rising occurrence of kidney diseases and urinary tract infections, implementation of the Patient Protection and Affordable Care Act (PPACA) in the U.S., technological advancements, and growing elderly population are other aspectsexpected to drive market growth.

According to the National Centre for Health Statistics, Urinary tract infections are the second-most common type of infections, accounting for about 8.1 million visits to healthcare workers each year. In the U.S., over 20 million people suffer from some type of chronic kidney disease (Source: Centres for Disease Control and Prevention (CDC)).

One of the major factors boosting the market growth for urology lasers is the implementation of minimally intrusive surgical techniques in holmium systems as well as thulium laser treatment systems. These systems provide several benefits such as greater efficacy, safety, and speedy recovery, which has caused in increased demand for holmium and thulium systems. These systems have provided fruitfulconsequences while reducing the side effects of treatment, and offer benefits such as shorter hospital stays, faster recovery, decrease in blood loss, and lower general body pain as a result of smaller cuts. Thus, the effectiveness and safety characteristics of these systems are expected to drive the growth of the market.

Segment Analysis
The increasing cases of urological illnesses such as urolithiasis, bladder cancer, urinary calculi, and prostate diseases, the demand for urology lasers has increased extensively. Asia Pacific is expected to be the fastest-growing regional market over the analysis period primarilydue to the increasing number of patients with urology-related disorders. According to the National Centre for Biotechnology Information (NCBI), in West Asia, Southeast Asia, South Asia, as well as some developed countries (South Korea and Japan), the incidence of urological disorders is 5% to 19.1%.

Competitive Landscape
Some of the major players in the global endourology equipment & consumables market include Olympus Corporation (Japan), Ethicon, Inc. (U.S.), Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Richard Wolf GmbH (Germany), Cook Medical Incorporated (U.S.), KARL STORZ GmbH (Germany), Lumenis Ltd. (Israel), and others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Big Data Analytics in Healthcare Market Report 2021-2031

Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice based on customized medical history record reviews and general medical information derived from big data inferences.

13 May 2021

Read

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

Read

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

Read

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever